GSRS was positively associated with CD8⁺ T cell infiltration levels in KIRC tissues. by Yu Zhang (12946)

Subjects:

Pan-cancer analyses of GSRS. by Yu Zhang (12946)

Subjects:

The primer sequence used in this study. by Yu Zhang (12946)

Subjects:

Schematic overview of the study workflow. by Yu Zhang (12946)

Subjects:

The tumor volume (mm³) of the mice in each group. by Yu Zhang (12946)

Subjects:

Unsupervised clustering of TCGA-KIRC subjects based on glucocorticoid signaling-related genes. by Yu Zhang (12946)

Subjects:

Differential expression of glucocorticoid signaling-related genes between paracarcinoma and KIRC tissues in the TCGA-KIRC cohort. by Yu Zhang (12946)

Subjects:

Patient status overview. by Farayi Kaseke (19560197)

Subjects:

Clinicopathological associations of GSRS. by Yu Zhang (12946)

Subjects:

Development and validation of the GSRS. by Yu Zhang (12946)

Subjects:

Real-time quantitative PCR (RT-qPCR) analysis was performed to validate the knockdown efficiency of NFKB2 in Renca cells. by Yu Zhang (12946)

Subjects:

The predictive efficacy of GSRS in combination with GR and/or HSD11B1 for the prognosis of KIRC patients. by Yu Zhang (12946)

Subjects:

Elevated serum glucocorticoid levels in KIRC patients and their positive correlation with disease malignancy. by Yu Zhang (12946)

Subjects:

Knockdown of Nfkb2 inhibited tumor growth and TEX levels <i>in vivo.</i> by Yu Zhang (12946)

Subjects:

Landmark prospective studies on the impact of T classification and LN involvement on the survival of AC. by Aihong Zheng (20571034)

Subjects:

This is the data set that we used to reach the conclusions drawn in the manuscript with related metadata and methods. by Farayi Kaseke (19560197)

Subjects:

Boxplots of morphological parameters between racial groups. by Zoë Dinkel (21402766)

Subjects:

Changes in average BD, PD, and TP of rhizosphere soil (0–60 cm) under different treatments before and after the experiment. by Hongyi Pan (5706971)

Subjects:

Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”